Capital Planning Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Sell
3,134
-198
-6% -$80.3K 0.19% 68
2025
Q1
$1.66M Sell
3,332
-125
-4% -$62.2K 0.26% 60
2024
Q4
$1.8M Sell
3,457
-7,299
-68% -$3.8M 0.28% 60
2024
Q3
$6.65M Buy
10,756
+109
+1% +$67.4K 1% 26
2024
Q2
$5.89M Buy
10,647
+101
+1% +$55.9K 1.01% 26
2024
Q1
$6.13M Sell
10,546
-149
-1% -$86.6K 1.08% 25
2023
Q4
$5.68M Buy
10,695
+146
+1% +$77.5K 1.07% 22
2023
Q3
$5.34M Sell
10,549
-92
-0.9% -$46.6K 1.11% 23
2023
Q2
$5.55M Buy
10,641
+18
+0.2% +$9.39K 1.13% 23
2023
Q1
$6.12M Sell
10,623
-633
-6% -$365K 1.3% 19
2022
Q4
$6.2M Sell
11,256
-171
-1% -$94.2K 1.47% 21
2022
Q3
$5.8M Buy
11,427
+29
+0.3% +$14.7K 1.56% 20
2022
Q2
$6.19M Buy
11,398
+39
+0.3% +$21.2K 1.64% 19
2022
Q1
$6.71M Sell
11,359
-227
-2% -$134K 1.43% 19
2021
Q4
$7.73M Buy
11,586
+19
+0.2% +$12.7K 1.47% 18
2021
Q3
$6.61M Sell
11,567
-158
-1% -$90.3K 1.37% 17
2021
Q2
$5.92M Sell
11,725
-356
-3% -$180K 1.21% 20
2021
Q1
$5.51M Sell
12,081
-788
-6% -$360K 1.24% 22
2020
Q4
$5.99M Sell
12,869
-717
-5% -$334K 1.47% 19
2020
Q3
$6M Buy
13,586
+161
+1% +$71.1K 1.64% 17
2020
Q2
$4.86M Buy
13,425
+130
+1% +$47.1K 1.45% 21
2020
Q1
$3.77M Sell
13,295
-186
-1% -$52.7K 1.41% 20
2019
Q4
$4.38M Buy
13,481
+59
+0.4% +$19.2K 1.15% 29
2019
Q3
$3.91M Sell
13,422
-560
-4% -$163K 1.14% 27
2019
Q2
$4.11M Buy
13,982
+59
+0.4% +$17.3K 1.21% 24
2019
Q1
$3.81M Buy
13,923
+246
+2% +$67.3K 1.16% 26
2018
Q4
$3.06M Buy
13,677
+1,671
+14% +$374K 1.11% 27
2018
Q3
$2.93M Buy
12,006
+2,324
+24% +$567K 0.94% 35
2018
Q2
$2.01M Buy
9,682
+647
+7% +$134K 0.91% 37
2018
Q1
$1.87M Buy
9,035
+299
+3% +$61.7K 0.66% 46
2017
Q4
$1.66M Buy
8,736
+7,456
+583% +$1.42M 0.58% 49
2017
Q3
$242K Buy
1,280
+30
+2% +$5.67K 0.09% 118
2017
Q2
$218K Buy
+1,250
New +$218K 0.1% 123
2015
Q2
Sell
-1,500
Closed -$202K 111
2015
Q1
$202K Buy
+1,500
New +$202K 0.14% 99